Literature DB >> 10574795

Binding of non-catalytic ATP to human hexokinase I highlights the structural components for enzyme-membrane association control.

C Rosano1, E Sabini, M Rizzi, D Deriu, G Murshudov, M Bianchi, G Serafini, M Magnani, M Bolognesi.   

Abstract

BACKGROUND: Hexokinase I sets the pace of glycolysis in the brain, catalyzing the ATP-dependent phosphorylation of glucose. The catalytic properties of hexokinase I are dependent on product inhibition as well as on the action of phosphate. In vivo, a large fraction of hexokinase I is bound to the mitochondrial outer membrane, where the enzyme adopts a tetrameric assembly. The mitochondrion-bound hexokinase I is believed to optimize the ATP/ADP exchange between glucose phosphorylation and the mitochondrial oxidative phosphorylation reactions.
RESULTS: The crystal structure of human hexokinase I has been determined at 2.25 A resolution. The overall structure of the enzyme is in keeping with the closed conformation previously observed in yeast hexokinase. One molecule of the ATP analogue AMP-PNP is bound to each N-terminal domain of the dimeric enzyme in a surface cleft, showing specific interactions with the nucleotide, and localized positive electrostatic potential. The molecular symmetry brings the two bound AMP-PNP molecules, at the centre of two extended surface regions, to a common side of the dimeric hexokinase I molecule.
CONCLUSIONS: The binding of AMP-PNP to a protein site separated from the catalytic centre of human hexokinase I can be related to the role played by some nucleotides in dissociating the enzyme from the mitochondrial membrane, and helps in defining the molecular regions of hexokinase I that are expected to be in contact with the mitochondrion. The structural information presented here is in keeping with monoclonal antibody mapping of the free and mitochondrion-bound forms of the enzyme, and with sequence analysis of hexokinases that differ in their mitochondria binding properties.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10574795     DOI: 10.1016/s0969-2126(00)80032-5

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  10 in total

1.  Structural studies of ROK fructokinase YdhR from Bacillus subtilis: insights into substrate binding and fructose specificity.

Authors:  B Nocek; A J Stein; R Jedrzejczak; M E Cuff; H Li; L Volkart; A Joachimiak
Journal:  J Mol Biol       Date:  2010-12-23       Impact factor: 5.469

2.  Crystal structure of a type III pantothenate kinase: insight into the mechanism of an essential coenzyme A biosynthetic enzyme universally distributed in bacteria.

Authors:  Kun Yang; Yvonne Eyobo; Leisl A Brand; Dariusz Martynowski; Diana Tomchick; Erick Strauss; Hong Zhang
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

3.  Crystal structures of Escherichia coli ATP-dependent glucokinase and its complex with glucose.

Authors:  Vladimir V Lunin; Yunge Li; Joseph D Schrag; Pietro Iannuzzi; Miroslaw Cygler; Allan Matte
Journal:  J Bacteriol       Date:  2004-10       Impact factor: 3.490

4.  Post-translational Regulation of Hexokinase Function and Protein Stability in the Aestivating Frog Xenopus laevis.

Authors:  Christine L Childers; Kenneth B Storey
Journal:  Protein J       Date:  2016-02       Impact factor: 2.371

5.  A dominant mutation in hexokinase 1 (HK1) causes retinitis pigmentosa.

Authors:  Lori S Sullivan; Daniel C Koboldt; Sara J Bowne; Steven Lang; Susan H Blanton; Elizabeth Cadena; Cheryl E Avery; Richard A Lewis; Kaylie Webb-Jones; Dianna H Wheaton; David G Birch; Razck Coussa; Huanan Ren; Irma Lopez; Christina Chakarova; Robert K Koenekoop; Charles A Garcia; Robert S Fulton; Richard K Wilson; George M Weinstock; Stephen P Daiger
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-04       Impact factor: 4.799

6.  Quantitative LC-MS/MS Analysis of Proteins Involved in Metastasis of Breast Cancer.

Authors:  Rieko Goto; Yasushi Nakamura; Tomonori Takami; Tokio Sanke; Zenzaburo Tozuka
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

7.  Hexokinase I N-terminal based peptide prevents the VDAC1-SOD1 G93A interaction and re-establishes ALS cell viability.

Authors:  Andrea Magrì; Ramona Belfiore; Simona Reina; Marianna Flora Tomasello; Maria Carmela Di Rosa; Francesca Guarino; Loredana Leggio; Vito De Pinto; Angela Messina
Journal:  Sci Rep       Date:  2016-10-10       Impact factor: 4.379

8.  Plasmodium vivax and human hexokinases share similar active sites but display distinct quaternary architectures.

Authors:  Shanti Swaroop Srivastava; Joseph E Darling; Jimmy Suryadi; James C Morris; Mark E Drew; Sriram Subramaniam
Journal:  IUCrJ       Date:  2020-03-26       Impact factor: 4.769

9.  Potassium ions promote hexokinase-II dependent glycolysis.

Authors:  Helmut Bischof; Sandra Burgstaller; Anna Springer; Lucas Matt; Thomas Rauter; Olaf A Bachkönig; Tony Schmidt; Klaus Groschner; Rainer Schindl; Tobias Madl; Nikolaus Plesnila; Robert Lukowski; Wolfgang F Graier; Roland Malli
Journal:  iScience       Date:  2021-03-22

10.  UDP-Glucose: A Cereblon-Dependent Glucokinase Protein Degrader.

Authors:  Jaeyong Cho; Atsushi Miyagawa; Kazuki Yamaguchi; Wakana Abe; Yoji Tsugawa; Hatsuo Yamamura; Takeshi Imai
Journal:  Int J Mol Sci       Date:  2022-08-13       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.